Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a parallel-track, randomized study will observe whether intravenous ascorbic acid reduces the reported fatigue in women receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer.
Epistemonikos ID: 50bb4b5ca4a387e83e58c18b5d5ef7d14986b234
First added on: May 12, 2024